Opportunity Information: Apply for PA 15 052
Apply for PA 15 052
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Lab to Marketplace Tools for Biomedical and Behavioral Research (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351 Research Infrastructure Programs.
- This funding opportunity was created on Nov 24, 2014 and posted on Nov 24, 2014.
- Applicants must submit their applications by Jan 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
- Other Eligible Applicants include the following Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria 1. Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor 2. Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture 3. i. SBIR and STTR. Be a concern which is more than 50 directly owned and controlled by one or more individuals (who are citizens or permanent resident aliens of the United States), other business concerns (each of which is more than 50 directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States), or any combination of these OR ii. SBIR only. Be a concern which is more than 50 owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these. No single venture capital operating company, hedge fund, or private equity firm may own more than 50 of the concern OR iii. SBIR and STTR. Be a joint venture in which each entity to the joint venture must meet the requirements set forth in paragraph 3 (i) or 3 (ii) of this section. A joint venture that includes one or more concerns that meet the requirements of paragraph (ii) of this section must comply with 121.705(b) concerning registration and proposal requirements. 4. Has, including its affiliates, not more than 500 employees.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Lab to Marketplace Tools for Biomedical and Behavioral Research (R43/R44) opportunity (Funding Opportunity Number PA 15-052) is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant program designed to help move promising research tools out of academic or other non-small-business settings and into the commercial marketplace. The core purpose is technology translation: taking tools that already exist in a research environment and investing additional development so they can be broadly distributed and used by the wider biomedical and behavioral research community. Rather than funding early-stage discovery science, the emphasis is on advancing tools that have already been created and shown enough value that they are worth productizing for real-world use.
This FOA specifically encourages small businesses to propose projects that make these research technologies more robust, more user-friendly, and more ready for commercial dissemination. In practical terms, that often means engineering and product development work such as improving reliability and performance, simplifying workflows, improving usability and documentation, expanding compatibility with common laboratory or clinical research environments, strengthening quality control, and preparing a tool for distribution and support. The overarching idea is to bridge the gap between a tool that works in the hands of its inventors and a tool that can be adopted, maintained, and supported at scale by many external users.
A defining feature of this program is the expectation of close collaboration between the small business applicant and the original developers of the technology, who are often based in universities, medical centers, or other research institutions. The FOA signals that successful projects will likely require active partnership to transfer know-how, refine requirements based on real research use cases, and ensure the commercial version remains scientifically valid and useful. NIH also notes that collaboration can be structured in different ways, including using multiple principal investigators, which can help formalize joint leadership between the small business team and the academic inventors.
The funding instrument is a grant, and the mechanism is R43/R44, which corresponds to SBIR Phase I (R43) and SBIR Phase II (R44). Phase I typically supports early feasibility and proof-of-concept work needed to demonstrate that the proposed productization path is viable, while Phase II supports more advanced development steps needed to prepare for commercialization. This FOA sits in the NIH Health funding activity category and is associated with CFDA number 93.351 (Research Infrastructure Programs). There is no cost sharing or matching requirement, which means applicants are not required to provide matching funds as a condition of receiving the award.
Eligibility is limited to United States small business concerns (SBCs). To qualify as an SBC at the time of award for Phase I and Phase II, the business must be organized for profit, have a place of business in the United States, and operate primarily in the United States or otherwise make a significant contribution to the U.S. economy through taxes or the use of American products, materials, or labor. It must be organized under an allowable legal structure (for example, sole proprietorship, partnership, LLC, corporation, joint venture, association, trust, or cooperative), and joint ventures must have less than 50 percent participation by foreign business entities. Ownership and control rules also apply. In many cases, the firm must be majority owned and controlled by U.S. citizens or permanent residents (directly or through qualifying entities), though the FOA includes SBIR-specific allowances for ownership by venture capital operating companies, hedge funds, and private equity firms as long as no single such entity owns more than 50 percent. Finally, the company (including affiliates) must have no more than 500 employees.
Administratively, the opportunity was posted and created on November 24, 2014, with an original and current closing date of January 7, 2018, and it was archived on February 7, 2018. The sponsoring agency is NIH. The full announcement was available via the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PA-15-052.html (as referenced in the source data). For access issues or broken links, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs): Lab to Marketplace Tools for Biomedical and Behavioral Research (R43/R44) - PA 15-052
What is the PA 15-052 opportunity?
PA 15-052 is an NIH Small Business Innovation Research (SBIR) grant opportunity titled "Lab to Marketplace Tools for Biomedical and Behavioral Research (R43/R44)." It supports small businesses that want to take promising biomedical or behavioral research tools that already exist in a research environment and further develop them for broader distribution and use in the commercial marketplace.
What is the main purpose of this SBIR program?
The core purpose is technology translation: moving research tools out of academic or other non-small-business settings and into the hands of the wider biomedical and behavioral research community. The focus is on productizing and preparing an existing tool for real-world dissemination and support, not on funding early-stage discovery science.
What kinds of projects does the FOA encourage?
The FOA encourages projects that make existing research technologies more robust, more user-friendly, and more ready for commercial dissemination. This often includes engineering and product development work to bridge the gap between a tool that works for its inventors and a tool that can be adopted and supported at scale by many external users.
What types of development activities are emphasized?
Emphasized activities include improving reliability and performance, simplifying workflows, enhancing usability and documentation, expanding compatibility with common laboratory or clinical research environments, strengthening quality control, and preparing the tool for distribution and support.
Is this opportunity intended for early-stage discovery research?
No. The emphasis is on advancing tools that have already been created and have demonstrated enough value to justify additional development for broad adoption. It is positioned as translation and productization rather than early-stage discovery science.
Who is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH).
What funding mechanism is used?
The mechanism is R43/R44, which corresponds to SBIR Phase I (R43) and SBIR Phase II (R44). The funding instrument is a grant.
What is the difference between SBIR Phase I (R43) and Phase II (R44) in this FOA?
Phase I (R43) typically supports early feasibility and proof-of-concept work to show the proposed productization path is viable. Phase II (R44) supports more advanced development steps needed to prepare the tool for commercialization.
What is the program expecting regarding collaboration with the original technology developers?
A defining feature is the expectation of close collaboration between the small business applicant and the original developers of the technology, who are often based in universities, medical centers, or other research institutions. The FOA indicates that successful projects will likely require active partnership to transfer know-how, refine requirements based on real use cases, and ensure the commercial version remains scientifically valid and useful.
Can collaboration be structured with multiple principal investigators (PIs)?
Yes. The FOA notes that collaboration can be structured in different ways, including using multiple principal investigators, which can help formalize joint leadership between the small business team and the academic inventors.
Who is eligible to apply?
Eligibility is limited to United States small business concerns (SBCs).
What are the basic small business concern (SBC) requirements described in the opportunity?
To qualify as an SBC at the time of award for Phase I and Phase II, the business must be organized for profit, have a place of business in the United States, and operate primarily in the United States or otherwise make a significant contribution to the U.S. economy through taxes or the use of American products, materials, or labor.
What legal structures are allowable for an eligible SBC?
The business must be organized under an allowable legal structure, such as a sole proprietorship, partnership, LLC, corporation, joint venture, association, trust, or cooperative.
Are joint ventures allowed, and are there restrictions involving foreign entities?
Joint ventures are allowable, but they must have less than 50 percent participation by foreign business entities.
Are there ownership and control rules for eligibility?
Yes. Ownership and control rules apply. In many cases, the firm must be majority owned and controlled by U.S. citizens or permanent residents (directly or through qualifying entities). The FOA also includes SBIR-specific allowances for ownership by venture capital operating companies, hedge funds, and private equity firms, as long as no single such entity owns more than 50 percent.
Is there an employee count limit for eligibility?
Yes. The company (including affiliates) must have no more than 500 employees.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of receiving the award.
What is the funding activity category and CFDA number associated with this FOA?
This FOA is in the NIH Health funding activity category and is associated with CFDA number 93.351 (Research Infrastructure Programs).
When was this opportunity posted and what are the key dates provided?
The opportunity was posted and created on November 24, 2014. The original and current closing date listed is January 7, 2018. The opportunity was archived on February 7, 2018.
Where can the full announcement be found?
The full announcement was available via the NIH Grants Guide at http://grants.nih.gov/grants/guide/pa-files/PA-15-052.html
Who should be contacted for access issues or broken links to the announcement?
For access issues or broken links, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: SBIR/STTR 2015 Phase I Release 2
Previous opportunity: Novel Assays for Screening the Effects of Chemical Toxicants on Cell Differentiation (R43/R44)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 052
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 052) also looked into and applied for these:
| Funding Opportunity |
|---|
| Underactive Bladder in Aging (R03) Apply for PA 15 050 Funding Number: PA 15 050 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Underactive Bladder in Aging (R21) Apply for PA 15 051 Funding Number: PA 15 051 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| PPHF 2015 Preventive Health and Health Services Block Grants Behavioral Risk Factor Surveillance System (Pacific Jurisdictions) Financed in Part by 2015 Prevention and Public Health Funds Apply for CDC RFA DP15 1513 Funding Number: CDC RFA DP15 1513 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Alzheimers Disease Sequencing Project (ADSP) Replication Phase Analysis Studies (U01) Apply for RFA AG 16 002 Funding Number: RFA AG 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| NIA Coordinating Center for Genetics and Genomics of Alzheimers Disease (U54) Apply for RFA AG 16 001 Funding Number: RFA AG 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) Apply for RFA HL 16 006 Funding Number: RFA HL 16 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sickle Cell Disease Newborn Screening Program Apply for HRSA 15 078 Funding Number: HRSA 15 078 Agency: Health Resources and Services Administration Category: Health Funding Amount: $2,679,000 |
| Alcohol Education Project Grants (R25) Apply for PAR 15 054 Funding Number: PAR 15 054 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Innovative Measures of Oral Medication Adherence for HIV Treatment and Prevention (R01) Apply for RFA AI 14 071 Funding Number: RFA AI 14 071 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Evaluation Capacity within the Government of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1589 Funding Number: CDC RFA GH15 1589 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Partnering with Pasteur Institute of Ho Chi Minh City to Enhance Regional Capacity to Prevent, Detect, Monitor, and Respond to the HIV/AIDS Epidemic in Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1595 Funding Number: CDC RFA GH15 1595 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Statewide Family Network Program Apply for SM 15 001 Funding Number: SM 15 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $95,000 |
| Statewide Consumer Network Program Apply for SM 15 002 Funding Number: SM 15 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $95,000 |
| Service Area Competition Additional Areas (SAC AA) Green Valley, AZ Wichita, KS Franklin, NH Washington, NC and Cheyenne, WY Apply for HRSA 15 139 Funding Number: HRSA 15 139 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator Directed Therapeutics (R41) Apply for RFA HL 15 026 Funding Number: RFA HL 15 026 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator Directed Therapeutics (R43/R44) Apply for RFA HL 15 027 Funding Number: RFA HL 15 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High Priority Immunology Grants (R01) Apply for PAS 15 055 Funding Number: PAS 15 055 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Perinatal and Infant Oral Health Quality Improvement Expansion Grant Program Apply for HRSA 15 070 Funding Number: HRSA 15 070 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Advanced Nursing Education Program Apply for HRSA 15 046 Funding Number: HRSA 15 046 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R21) Apply for PA 15 057 Funding Number: PA 15 057 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 052", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.